Abstract: DOXO (doxorubicin), an anthracycline antibiotic with the multidirectional cytotoxic effects that have been attributed to its capability to generate free radicals (ROS), induces apoptosis in transformed and non-transformed cells. In the present study a eukaryotic organism, Candida utilis was used to evaluate the effect of Doxorubicin on the activity of some redox enzymes like, CAT (catalase), SOD (superoxide dismutase) and peroxidase, the amount of some hemoproteines of respiratory chain, and on cell growth and viability. Cells were cultured in minimal medium with 1.5% ethanol as substrate, in the presence of 1-160 µg/mL Doxorubicin. Doxorubicin treatment, showed a dose-dependent decrease in cell proliferation and cell viability despite an increase in trypan-blue positive cells. CAT, SOD and peroxidase activity decreased as Doxorubicin concentration increased, while CAT, SOD and peroxidase activity reduced to 0%, 21%, and 2% of the control value in the presence of 160 µg/mL Doxorubicin. Cells cultured in the presence of Doxorubicin showed alterations in their respiratory chain and decrease in their cytochrome content, indeed the Doxorubicin effect on the amount of cytochrome c oxidase was more severe than that of cytochromes c and b. Generally, Doxorubicin reduced the ROS-scavenging systems and induced a ROS-generation apoptosis in Candida utilis.
Introduction
 DOXO (doxorubicin), isolated more than forty years ago from Streptomyces peucetius, is an anthracycline antibiotic very effective against solid and hematologic malignancies [1] . However its clinical use is restricted because of severe toxic side-effects that contain cumulative and dose-dependent cardiotoxicity, nephrotoxicity, hepatotoxicity and skin toxicity [2] . In spite of all, it remains among the most effective anticancer drug ever developed and plays a major role in cancer chemotherapy. At the first look DOXO is an anti-cancer agent which makes hydrogen bonds and van der waales interactions with DNA, cause inhibition of macromolecular biosynthesis, and to reduce the function of topoisomerase II throughout transcription and replication [3] . In 1996 it was cleared that DOXO toxicity mediated by semiquinone-free radicals derived from the drug itself and ROS (reactive oxygen species) generation [4] .
Recently, we learned that a key factor in the response of cancer cells to chemotherapeutic drugs is the activation of the apoptotic pathway and doxorubicin induced apoptosis in endothelial, human colon and kidney cells [5] [6] [7] [8] , also apoptosis is a pathway that often induce and continue by ROS [9] . It has been proposed that doxorubicin toxicity is connected mainly to its ability to generate free radicals and there is a large deal of supportive proof for this theory [10] [11] [12] [13] [14] [15] . Single electrons are transported to doxorubicin, giving rise to oxygen radicals through the auto-oxidation of doxorubicin semiquinones, [16, 17] under aerobic conditions this semiquinone free radicals produces O 2 -(superoxide anion), H 2 O 2 (hydrogen peroxide) and OH (hydroxyl radical) [18] .
Indeed there is an increasing interest in interfacing the studies on Doxorubicin-induced apoptosis by investigating different proteins and pathways. Now we
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418 learned that DOXO induced the activation of MAPK (mitogen-activated protein kinase) pathways [19] , p38 MAPK which induces apoptosis in cardiac cells and EPK (extracellular signal regulated kinases) [20] [21] [22] . Also Inhibition of Fas anti apoptotic proteins like Bcl-2 and the tumor suppressor protein p53 are involved in Doxorubicin-induced apoptosis [23] [24] [25] . Moreover plasma membrane alteration [26] and mitochondrial dysfunction [27] are also reported in Doxorubicin-induced apoptosis. The general consensus is that DOXO toxicity is highly linked to free radical generation, particularly in mitochondria, on the other hand ROS-scavenging enzymes like SOD (superoxide dismutase), CAT (catalase) and peroxidases have been shown to supply some protection against oxidative stress. SOD as the first defense enzyme against oxidative stress produces hydrogen peroxide from superoxide anion radicals, then CAT and peroxidase use hydrogen peroxide for reduction [18] . However little is known about the effect of DOXO on ROS-scavenging enzymes activity. The main purpose of this in vivo investigation was to evaluate the effect of Doxorubicin on the activity of three anti-ROS enzymes; SOD, CAT and peroxidase as the first line of defense against oxidative stress, as well as the growth curve, cell viability and respiratory chain alterations in Candida utilis as a eukaryotic model, under treatment of increasing concentrations of Doxorubicin.
Materials and Methods
Materials
Doxorubicin hydrochloride (Adriamycin®) was obtained from Ebewe Pharma (Austria), yeast Candida utilis was the strain ATCC 8305 and all other chemicals used in this work were obtained from Merk (Darmstadt, Germany) and were of reagent grade.
Methods
Growth Conditions
Candida utilis, (strain ATCC 8205) was cultured at 29°C in a rotary shaker (at 130 rpm), in a synthetic medium [28] Fig. 1 shows the growth curves obtained by examining the increase in cell concentration determined at timed intervals by spectrophotometer for Candida utilis, cultured in liquid synthetic medium in the presence of increasing Doxorubicin concentrations (1-160 µg/mL). A gradual decrease in cell growth was registered as a function of Doxorubicin concentration, moreover increasing DOXO caused a progressive increase in the duration of lag phase and of the log phase while the growth rate decreased. It went from a 6% decrease after growth in 5 µg/mL DOXO to a 96% decrease after growth in the presence of 160 µg/mL DOXO. The serial dilutions of cells cultured in the presence of increasing concentrations of DOXO, plated on enriched agar medium, colony count after 24 h revealed that, cell viability also decreased as DOXO increased, it went from 89% of control in 5 µg/mL DOXO to 1% of control in the presence of 160µg/mL Doxorubicin (Fig. 2a) . Furthermore the assessment of cells after trypan blue staining also exposed the number of blue cells increased from 4% to 88% after culture in Doxorubicin concentrations from 5 to 160µg/mL (Fig.  2b) . On the contrary percentage of 1µg/mL DOXO revealed different results, cell growth increased up to 2%, the duration of lag and log phase decreased (Fig. 1) and compared with the control cell viability increased by 2.5% (Fig. 2a) .
Results
Effect of Doxorubicin on Cell Growth and Cell Viability
Effect of Doxorubicin on Enzyme Activities
The variations in SOD activity shown in Fig. 3a, as shown in this figure the SOD activity decreased to 21% of the control value in 160 µg/mL DOXO. Compare to the control, in 1 µg/mL DOXO the SOD activity showed 2% increase. CAT activity dropped abruptly to 62% in 1 µg/mL DOXO, then there was a progressively DOXO concentration dependent decrease in enzyme activity which revealed 2% activity in 80 µg/mL DOXO (Fig. 2b) . Also it was discovered that the steep decline for CAT activity is faster than SOD activity, and 21% SOD activity was still detectable in 160 µg/mL DOXO while CAT activity was not detectable in the same concentration of DOXO. The decreasing pattern was repeated for peroxidase activity, as shown in Fig. 3c the peroxidase activity dropped to 58% of control value in1 µg/mL DOXO, then decreased progressively as DOXO concentration increased, finally it showed 2% activity in 160 µg/mL DOXO. Moreover the steep decline of peroxidase activity was similar to CAT activity. Collectively SOD activity was more protected against doxorubicin toxicity.
Effect of Doxorubicin on Cytochrome Content
Examination of the cytochrome content in cells grown in the absence of Doxorubicin and in the presence of 1-160 µg/mL DOXO revealed that cytochrome c oxidase was the most sensitive hemoprotein as illustrated in Fig. 4 . The amount of cytochrome c oxidase in cells grown in 1, 5 µg/mL DOXO was, respectively, 117% and 110% of the control value, then a progressive decrease in cytochrome c oxidase content was detected as shown in Fig. 4 . The amount of cytochrome c oxidase decreased from 71% to 21% of the control value in cells grown in 10-160 µg/mL DOXO. The amount of cytochrome c detectable for cells grown in 1 µg/mL doxorubicin, was 116% of the control value and for higher concentrations (5-160 µg/mL DOXO) the cytochrome c content was dropped from 96% to 50% of the control value (Fig. 4) . Finally the amount of cytochrome b was respectively, 110% and 105% of the control value for cells grown in 1, 5 µg/mL DOXO, then the amount of cytochrome b decreased with a low slope. As shown in the Fig. 4 the amount of cytochrome b decreased from 93% to 74% of the control value for the cells grown in 10-160 µg/mL DOXO and collectively results showed that cytochrome b was the hemoprotein least sensitive to Doxorubicin.
Discussion
Doxorubicin can cause the formation of ROS which are responsible for the side effects of toxicity obtained by the drug use, during these same mechanisms make doxorubicin a powerful anticancer drug, allowing it to be effective against a variety of cancer tumors [32] and it has been generally accepted that DOXO exerts its anticancer effect by inducing apoptosis [33] . A variety of cell death pathways are now under consideration, wide research revealed that apoptosis is a multifaceted process which can control cell death during two major routes mediated either by plasma membrane or by mitochondrial outer membrane permeability [28] . Many factors and organelles are involved in apoptosis but the exact mechanisms stay to be clarified. Recently, several studies have shown that mitochondrial ROS is involved in the apoptotic process, then reported that DOXO-induced apoptosis in platelets and mitochondrial ROS involved in mentioned process [33] .
In this investigation, cell yield and viability count showed that Doxorubicin, in low concentration (1 µg/mL) stimulated cell proliferation and cell viability. Recent evidence preserves the concept that low concentrations of ROS are able to stimulate cell proliferation and it is becoming clear that Doxorubicin cytotoxicity mediated by ROS [4] . On the other hand in the presence of 1 µg/mL DOXO, the SOD activity and cytochrome content were increased. Doxorubicin produces superoxide anion radicals which convert to hydrogen peroxide by SOD activity, Then CAT and peroxidase use this hydrogen peroxide for reduction [34] . As shown in Fig. 3a the SOD activity is more protected against DOXO toxicity, so superoxide anion radicals (produced by Doxorubicin), convert to hydrogen peroxide by up-regulation of SOD activity, but the other redox enzymes (CAT and peroxidases) which highly inhibited by DOXO toxicity (Figs. 3b and  3c ) may perhaps not able to use hydrogen peroxide. Then the accumulation of hydrogen peroxide leads to oxidative stress determined by increase in the levels of hemoproteins of respiratory chain (Fig. 4) [30, 34] . Additionally, the production of oxidant radicals, especially hydrogen peroxide, is able to persuade cytochrome c release and causing apoptosis [33, 34] .
In the higher concentrations of Doxorubicin; growth curves, viability count and trypan blue exclusion showed that cell survival was reduced in a dose-dependent manner. Indeed results showed a significant decrease in antioxidant activities which providing protection against oxidative stress, thus the reduction in the activity of SOD, CAT and peroxidase, reported in this work reduced the ability of Candida utilis to fight the overproduction of ROS by DOXO and improved the drug adverse consequences. Overall measurements of respirations demonstrated that Doxorubicin was a potent uncoupler of oxidative On the other hand, it has been reported that DOXO could increase mitochondrial ROS production (33). As we learn before, mitochondria is the powerful ROS scavenger in cell physiology, these examinations designate that DOXO induce alterations in mitochondrial ability against oxidative stress caused by ROS. It has been previously reported that overproduction of ROS can start deadly chain reactions, which involve oxidant and damage arrangements that are critical for cell survival. Finally some antitumor drugs like Doxorubicin reveal antitumor activity using ROS-dependent activation of apoptotic cell death. This purpose could be attained by two methods explicitly; inducing the ROS production directly and reducing the antioxidant defense system of cells [35] . Doxorubicin generates ROS by semiquinone free radicals and reduced both enzymatic and mitochondrial oxidative defense systems as mentioned above. So according to our study, Doxorubicin regulates the ROS-generation apoptosis pathway in yeast Candida utilis by reducing redox systems.
Conclusion
Collectively our results showed that cell proliferation and survival was reduced in a 
